Clinical trial
Ropinirole Tablets In Young Patients With Restless Legs Syndrome
NCT00140712 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00140712 |
|---|---|
| Title | Ropinirole Tablets In Young Patients With Restless Legs Syndrome |
| Official title | A Study to Determine the Tolerability and Pharmacokinetics for Ropinirole in Paediatric / Adolescent Patients With RLS (Type 2) |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Restless Legs Syndrome |
| Intervention type | Drug |
| Interventions | Ropinirole Immediate Release |
| Enrollment | 9 |
| Start date | Jun 10, 2005 |
| Primary completion | Feb 28, 2008 |
| Completion | Feb 28, 2008 |
| First posted | Sep 1, 2005 |
| Last update posted | Sep 11, 2017 |
| Countries | Belgium, France, United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: